Jeffrey S. Glenn - 22 Dec 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc.

Role: Director
Signature: /s/ Sriram Ryali, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 22 Dec 2022
Net transactions value: +$127,950
Form type: 4
Filing time: 27 Dec 2022, 16:31:03 UTC
Previous filing: 11 Mar 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EIGR	Common Stock	Purchase	$127,950	+100,000	+121%	$1.28	182,355	22 Dec 2022	Direct	F1
holding	EIGR	Common Stock						5,000	22 Dec 2022	By spouse
holding	EIGR	Common Stock						460	22 Dec 2022	By son
holding	EIGR	Common Stock						151,064	22 Dec 2022	By Eiger Group International, Inc.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2	Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.